Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Quantification of the immune cell subsets (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
Immune cells will be analyzed for frequency and function by 10-color flow cytometry to test the reciprocal balance of protumor vs antitumor immune subsets. The analysis, based in the application of multiple panels of different antibodies, will be performed on peripheral blood mononuclear cells (PBMC) isolated from peripheral blood.
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Transcriptional Immune cell profiling (to determine if occur the re-setting antitumor immunity by short-term physical exercise)
CD14+, CD15+ and total immune cells will be immunosorted directly from whole blood (3 ml) and frozen for the targeted expression profiling of signaling pathways and functional patterns (Nanostring or customized PCR cards).
Analysis of the "systemic metabolic milieu"_AEPMet before
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor before
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf before
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip before
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts before
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 40
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 40
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 40
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 40
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 40
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 80
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 80
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 80
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 80
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 80
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 24
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 24
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 24
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 24
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 24
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_AEPMet 72
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_AEPHor 72
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_AEPInf 72
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_AEPLip 72
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_AEPcounts 72
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet before
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor before
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf before
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip before
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEP counts before
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet 1w
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor 1w
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf 1w
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip 1w
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEPcounts 1w
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the "systemic metabolic milieu"_CEPMet 2w
In plasma we will quantify pH, Lactate, Ketone bodies, Free Fatty Acids, Glucose and Insulin serum levels that will be combined to report the metabolic parameters
Analysis of the "systemic metabolic milieu"_CEPHor 2w
In serum we will quantify ACTH, cortisol, epinephrine and norepinephrine concentrations that will be combined to report the hormonal parameters
Analysis of the "systemic metabolic milieu"_CEPInf 2w
In blood we will quantify IL-6, CRP, inflammatory cito/chemokines such as IL8, CCL2, IFN, IL10, IL1b, TNFa, TGFb that will be combined to report the inflammatory parameters
Analysis of the "systemic metabolic milieu"_CEPLip 2w
We will analyze the Lipidomics and amino acid profiles by laboratory test that will be combined to report the composition of cell membranes
Analysis of the "systemic metabolic milieu"_CEPcounts 2w
Whole blood cell counts will be also performed; this parameter is characterized by the absolute number as well as relative ratio.
Analysis of the metabolic parameters by capillary sampling_AEPCap before
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 40
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 80
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 24
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_AEPCap 72
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap before
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap 2w
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).
Analysis of the metabolic parameters by capillary sampling_CEPCap end
Capillary sampling (prick sampling) to analysis metabolic parameters at systemic blood level will be performed during the first, in-hospital, training session and further will be continued at home, self-managed by the patient who will have to measure glycaemia and ketones every morning (finger prick sampling) and after each training sessions (earlobe prick sampling).